Metrics Contract Services Appoints Commercial Manufacturing BD Lead

Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose (OSD) products, has appointed Kim Black-Washington as Senior Business Development Executive.

Kim will be responsible for marketing Metrics’ expertise in the commercial manufacturing of complex and highly potent compounds following the recent opening of the company’s $10m, 3,760 square foot potent-capable production space, which was an additional expansion to the facility’s $100m commercial manufacturing building.

She joins from Catalent Pharma Solutions, where she was Director of Business Development, Clinical Supplies Services. She is a highly skilled sales and marketing professional with 15+ years of global experience in senior leadership roles within pharmaceutical, biotechnology, and medical device industries.

Kim will report to Britton Jimenez, Vice President of Business Development, who commented: “Metrics offers exceptional end-to-end services and has a reputation for leading science and great customer service in novel OSD development and manufacturing.

“We are seeing growing demand from clients looking to manufacture complex, often potent drug products. This is largely due to the focus on oncology in drug development pipelines. Our new commercial production suites offer increased flexibility and capacity to our partners and enable us to tailor equipment trains to their processes, particularly those that require smaller batch sizes.”

“By investing in dedicated capabilities and infrastructure, as well as adding experienced people like Kim to the team, we will ensure that we further expand our presence and reputation as a leading manufacturer of novel OSDs and help deliver vital medicines to patients everywhere.”

Metrics Contract Services specializes in potent novel OSD forms and offers quality pharmaceutical formulation development, clinical trial materials manufacturing for all phases, analytical method development and validation services and commercial scale manufacturing.

Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide delivering proven scientific and operational excellence for novel oral dosage forms. Metrics’ areas of expertise include quality pharmaceutical formulation development; first-time-in-human formulations; Phase I-III clinical trial materials manufacturing; and analytical method development and validation services leading to commercial scale manufacturing. Technical capabilities include highly potent and unstable compounds; Schedule II-V controlled substances; and products with poor bioavailability, for which we offer an impressive portfolio of advanced delivery methods. Metrics manufactured products are now approved by medicines regulators in more than 40 countries. Located in Greenville, N.C., Metrics is a proud member of Mayne Pharma. Learn more at: metricscontractservices.com.

Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on the application of drug delivery expertise to commercialize branded and generic pharmaceuticals. Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide.  Mayne Pharma has a 40-year track record of innovation and success in developing new oral drug delivery systems, and these technologies have been successfully commercialized in numerous products that continue to be marketed around the world. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, USA, with expertise in the formulation of complex oral and topical dose forms including potent compounds, modified-release products and poorly soluble compounds. For further information, visit: www.maynepharma.com.